Creo Medical Group PLC (AIM:CREO)

Market Cap	42.76M
Revenue (ttm)	30.30M
Net Income (ttm)	-22.40M
Shares Out	402.47M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	710,933
Average Volume	2,270,348
Open	10.58
Previous Close	10.63
Day's Range	10.15 - 10.75
52-Week Range	0.10 - 37.20
Beta	0.56
RSI	42.89
Earnings Date	May 12, 2025

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablation device; M...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 287
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: CREO

Financial Performance

In 2023, Creo Medical Group's revenue was 30.80 million, an increase of 13.24% compared to the previous year's 27.20 million. Losses were -21.70 million, -19.33% less than in 2022.